NCM
AGN

Northwest Capital Management’s Allergan plc AGN Stock Holding History

Northwest Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,500
Closed -$266K – 58
2020
Q1 		$266K Hold
1,500
– – 0.27% 44
2019
Q4 		$287K Hold
1,500
– – 0.26% 46
2019
Q3 		$252K Hold
1,500
– – 0.27% 49
2019
Q2 		$251K Hold
1,500
– – 0.27% 51
2019
Q1 		$220K Hold
1,500
– – 0.27% 59
2018
Q4 		$200K Hold
1,500
– – 0.28% 65
2018
Q3 		$286K Buy
+1,500
New +$276K 0.3% 54

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Northwest Capital Management's AGN Position: Q2 2020 in Review

Northwest Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,500 shares — an estimated $266K sold.

Northwest Capital Management first reported a position in AGN in Q3 2018 and held it in 7 quarters. The position peaked at $287K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Northwest Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Northwest Capital Management sold 1,500 Allergan plc shares in Q2 2020, an estimated $266K.
  • Northwest Capital Management first reported a position in Allergan plc in Q3 2018 and held it in 7 quarters.
  • Northwest Capital Management's Allergan plc position peaked at $287K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Northwest Capital Management's 13F filing for Q2 2020, filed 24 Jul 2020.